Decrease in Plasma B-Type Natriuretic Peptide Early After Initiation of Cardiac Resynchronization Therapy Predicts Clinical Improvement at 12 Months

Abstract

Percentage change in plasma BNP levels from baseline to 3 months was the strongest predictor of long-term response to CRT and may have potential to predict outcome.